Argonaut Ventures

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
3
in our dataset
Rounds participated
3
Rounds led
0
Rounds' value
$34.2M
total disclosed, rounds participated
Stages
—

Portfolio · 3

Actelis Networks
Networking Solutions for Wide-area IoT Networks
1 round $10.0M committed Latest: 2009-09
CorAssist
Preserved Ejection Fraction Heart Failure Treatment
1 round $5.2M committed Latest: 2009-03
Sol-Gel Technologies
Silica Microencapsulation Technology for Dermatological Drugs
1 round $19.0M committed

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences2
Business Software1

Q&A

What is Argonaut Ventures' most recent exit?
Argonaut Ventures' most recent exit was Actelis Networks, which went public on NASDAQ in May 2022 with a valuation of $70M.
Which sectors does Argonaut Ventures primarily invest in?
Argonaut Ventures primarily invests in Health Tech & Life Sciences and Business Software sectors, with two portfolio companies in Health Tech & Life Sciences and one in Business Software.
Can you name some of Argonaut Ventures' portfolio companies?
Argonaut Ventures' portfolio includes Actelis Networks, which provides networking solutions, and CorAssist, focused on heart failure treatment.
What was a notable past exit for Argonaut Ventures?
A notable past exit for Argonaut Ventures was Sol-Gel Technologies, which was acquired by Mori Arkin in July 2014.
What is the typical investment range for Argonaut Ventures?
Argonaut Ventures typically invests between $5.2M and $19M.